ストックスクリーナーアプリを入手
0.7399
4.29%
-0.0332
プレマーケット:
.71
-0.0299
-4.04%
Glucotrack Inc (GCTK) 最新ニュース
GCTK Stock Price, Quote & Chart | GLUCOTRACK INC (NASDAQ:GCTK) - ChartMill
What you need to know before buying GlucoTrack (GCTK) (+0.76%) 2026-05-08Mid Cap Momentum - newser.com
How GlucoTrack (GCTK) maintains its asset base | GCTK: GlucoTrack Q Results Lack Revenue, EPS DataGuidance Upgrade - newser.com
GlucoTrack Files IDE for Implantable Glucose Monitor - TipRanks
IDE filing advances Glucotrack (NASDAQ: GCTK) implantable glucose monitor - Stock Titan
Glucotrack Submits Blood Glucose Monitoring Technology to FDA - Yahoo Finance
Glucotrack Submits IDE to FDA for Implantable Continuous Blood Glucose Monitoring System - geneonline.com
Glucotrack submits FDA application for implantable glucose monitor - Investing.com
Glucotrack submits FDA application for implantable glucose monitor By Investing.com - Investing.com Canada
GlucoTrack, Inc. announced it has officially submitted an Investigational Device Exemption (IDE) application to US regulators for its innovative implantable continuous glucose monitoring technology. - Bitget
Glucotrack, Inc. Submits Investigational Device Exemption Application to FDA for Continuous Blood Glucose Monitoring Technology - Quiver Quantitative
Implantable diabetes monitor moves toward U.S. trial without a wearable - Stock Titan
Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology - marketscreener.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm
Glucotrack Announces IDE Submission for U.S. Clinical Study of Its Novel Implantable Continuous Blood Glucose Monitoring Technology - Moomoo
GCTK Stock Jumps As Implantable CGM Data Impresses - StocksToTrade
GCTK Jumps As GlucoTrack’s Implantable CGM Data Impresses - timothysykes.com
Needle-free diabetes care: 6 devices that painlessly monitor blood sugar - Labiotech.eu
see if this zone is the one. $Glucotrack (GCTK.US)$ - Moomoo
GlucoTrack Executes Debt-for-Equity Exchange and Investor Update - The Globe and Mail
GlucoTrack Reports Strong Preclinical Data for Implantable CBGM - The Globe and Mail
Peer-Reviewed Study in Journal of Diabetes Research Verifies Glucotrack’s Long‑Term Continuous Blood Glucose Monitoring Technology - citybiz
[EFFECT] Glucotrack, Inc. SEC Filing - Stock Titan
Glucotrack (NASDAQ: GCTK) swaps $988K debt for 1.3M new shares - Stock Titan
Glucotrack publishes 240-day glucose monitor study results By Investing.com - Investing.com South Africa
Peer-reviewed CBGM data back Glucotrack (NASDAQ: GCTK) IDE plans - Stock Titan
Glucotrack publishes 240-day glucose monitor study results - Investing.com
Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology - The Manila Times
An implantable glucose monitor held accuracy for 240 days in animal study - Stock Titan
Glucotrack, Inc. (NASDAQ: GCTK) registers 20.06M shares tied to $20M financing - Stock Titan
GCTK Stock Chops Higher As GlucoTrack Marks Key CGM Milestones - StocksToTrade
GCTK Stock Pops As GlucoTrack Marks Key CGM Milestones - timothysykes.com
GlucoTrack stock gains as data backs FDA filing plans for glucose monitoring tech - MSN
GCTK stock is soaring pre-market today — what is fueling the surge? - MSN
GlucoTrack Stock Short Interest Falls to 73.9% - Quiver Quantitative
GlucoTrack files to sell 20.06M shares of common stock by selling shareholders - MSN
GCTK GlucoTrack lays out new commercial growth plans in its latest quarterly earnings release for non-invasive glucose monitors.Dividend Report - Cổng thông tin điện tử tỉnh Tây Ninh
Study Supports GlucoTrack’s Blood Glucose Monitoring Implant - Yahoo Finance
GlucoTrack announces publication of peer-reviewed article on glucose sensors - TipRanks
New Peer-Reviewed Study Supports Glucotrack’s Long-Duration Implantable Continuous Blood Glucose Monitoring Technology - citybiz
Glucotrack publishes peer-reviewed study on glucose sensor stability - Investing.com
Glucotrack publishes peer-reviewed study on glucose sensor stability By Investing.com - Investing.com Canada
Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology - marketscreener.com
One-year lab test backs Glucotrack implantable glucose monitor - Stock Titan
GlucoTrack (GCTK) Stock Investment Today (Volatility Increases) 2026-04-20Turnaround Stocks - Cổng thông tin điện tử tỉnh Lào Cai
GCTK | GlucoTrack, Inc. Common Stock Insider Trading - Quiver Quantitative
GlucoTrack (GCTK) Stock Volume Drop (Smart Money Active) 2026-04-18Viral Momentum Stocks - newser.com
Should You Hold GlucoTrack (GCTK) Stock? (Technical Weakness) 2026-04-16Momentum Signals - Xã Vĩnh Công
2.05%
3.17%
大文字化:
|
ボリューム (24 時間):